Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan
· Delayed Price · Currency is TWD 60.80
+0.20 (0.33%)
Feb 14, 2025, 9:00 AM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 7.85 billion as of February 21, 2025. Its market cap has decreased by -18.04% in one year.
Market Cap
7.85B
Enterprise Value
6.36B
Revenue
50.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
60.80
Market Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has increased from 4.86B to 7.85B, an increase of 61.55%. That is a compound annual growth rate of 17.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 7.85B | 14.93% |
| Dec 31, 2024 | 6.83B | -33.79% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 209.72B |
| Caliway Biopharmaceuticals | 142.08B |
| Bora Pharmaceuticals Co., LTD. | 89.70B |
| Lotus Pharmaceutical | 72.59B |
| Lumosa Therapeutics | 39.86B |
| Oneness Biotech | 38.77B |
| Polaris Group | 36.08B |
| Pegavision | 30.30B |